Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 16.04.13 in Vol 15, No 4 (2013): April

This paper is in the following e-collection/theme issue:

Works citing "Use of a Text Message-Based Pharmacovigilance Tool in Cambodia: Pilot Study"

Sophie Baron, Flavie Goutard, Kunthy Nguon, Arnaud Tarantola

J Med Internet Res 2013 (Apr 16); 15(4):e68 

According to Crossref, the following articles are citing this article (DOI 10.2196/jmir.2477):

(note that this is only a small subset of citations)

  1. Vergeire-Dalmacion G, Castillo-Carandang NT, Juban NR, Amarillo ML, Tagle MP, Baja ES. Texting-Based Reporting of Adverse Drug Reactions to Ensure Patient Safety: A Feasibility Study. JMIR Public Health and Surveillance 2015;1(2):e12
    CrossRef
  2. Goel S, Bhatnagar N, Sharma D, Singh A. Bridging the Human Resource Gap in Primary Health Care Delivery Systems of Developing Countries With mHealth: Narrative Literature Review. JMIR mhealth and uhealth 2013;1(2):e25
    CrossRef
  3. Caillet C, Sichanh C, Syhakhang L, Delpierre C, Manithip C, Mayxay M, Lapeyre-Mestre M, Newton PN, Roussin A. Population awareness of risks related to medicinal product use in Vientiane Capital, Lao PDR: a cross-sectional study for public health improvement in low and middle income countries. BMC Public Health 2015;15(1)
    CrossRef
  4. Kim SS, Patel M, Hinman A. Use of m-Health in polio eradication and other immunization activities in developing countries. Vaccine 2017;35(10):1373
    CrossRef
  5. Ribeiro-Vaz I, Silva A, Costa Santos C, Cruz-Correia R. How to promote adverse drug reaction reports using information systems – a systematic review and meta-analysis. BMC Medical Informatics and Decision Making 2016;16(1)
    CrossRef
  6. Diallo MK, Diallo AO, Dicko A, Richard V, Espié E. Human rabies post exposure prophylaxis at the Pasteur Institute of Dakar, Senegal: trends and risk factors. BMC Infectious Diseases 2019;19(1)
    CrossRef
  7. Berrewaerts J, Delbecque L, Orban P, Desseilles M. Patient Participation and the Use of Ehealth Tools for Pharmacoviligance. Frontiers in Pharmacology 2016;7
    CrossRef
  8. Menezes N, Wali S, Ganachari M. Pharmacist-led intervention on adverse events following immunization at a tertiary care hospital: A randomized controlled study. Indian Journal of Health Sciences and Biomedical Research (KLEU) 2020;13(2):127
    CrossRef
  9. Leeb A, Regan AK, Peters IJ, Leeb C, Leeb G, Effler PV. Using automated text messages to monitor adverse events following immunisation in general practice. Medical Journal of Australia 2014;200(7):416
    CrossRef
  10. Iribarren SJ, Brown W, Giguere R, Stone P, Schnall R, Staggers N, Carballo-Diéguez A. Scoping review and evaluation of SMS/text messaging platforms for mHealth projects or clinical interventions. International Journal of Medical Informatics 2017;101:28
    CrossRef
  11. Ateudjieu J, Stoll B, Nguefack-Tsague G, Tchangou C, Genton B. Vaccines safety; effect of supervision or SMS on reporting rates of adverse events following immunization (AEFI) with meningitis vaccine (MenAfriVac™): A randomized controlled trial. Vaccine 2014;32(43):5662
    CrossRef
  12. Tozzi AE, Gesualdo F, D’Ambrosio A, Pandolfi E, Agricola E, Lopalco P. Can Digital Tools Be Used for Improving Immunization Programs?. Frontiers in Public Health 2016;4
    CrossRef
  13. Clothier HJ, Selvaraj G, Easton ML, Lewis G, Crawford NW, Buttery JP. Consumer reporting of adverse events following immunization. Human Vaccines & Immunotherapeutics 2014;10(12):3726
    CrossRef
  14. Brody C, Tuot S, Chhoun P, Swendenman D, Kaplan KC, Yi S. Mobile Link – a theory-based messaging intervention for improving sexual and reproductive health of female entertainment workers in Cambodia: study protocol of a randomized controlled trial. Trials 2018;19(1)
    CrossRef
  15. Goutard F, Binot A, Duboz R, Rasamoelina-Andriamanivo H, Pedrono M, Holl D, Peyre M, Cappelle J, Chevalier V, Figuié M, Molia S, Roger F. How to reach the poor? Surveillance in low-income countries, lessons from experiences in Cambodia and Madagascar. Preventive Veterinary Medicine 2015;120(1):12
    CrossRef
  16. Wilson K, Atkinson KM, Westeinde J, Bell C, Marty K, Fergusson D, Deeks SL, Crowcroft N, Bettinger JA. An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccination. Human Vaccines & Immunotherapeutics 2016;:1
    CrossRef
  17. Regan A, Blyth C, Tracey L, Mak D, Richmond P, Effler P. Comparison of text-messaging to voice telephone interviews for active surveillance of adverse events following immunisation. Vaccine 2015;33(31):3689
    CrossRef
  18. Agoro OO, Kibira SW, Freeman JV, Fraser HSF. Barriers to the success of an electronic pharmacovigilance reporting system in Kenya: an evaluation three years post implementation. Journal of the American Medical Informatics Association 2018;25(6):627
    CrossRef
  19. Gold M, Lincoln G, Bednarz J, Braunack-Mayer A, Stocks N. Consumer acceptability and validity of m-Health for the detection of adverse events following immunization – The Stimulated Telephone Assisted Rapid Safety Surveillance (STARSS) randomised control trial. Vaccine 2021;39(2):237
    CrossRef
  20. Brody C, Dhaliwal S, Tuot S, Johnson M, Pal K, Yi S. Are Text Messages a Feasible and Acceptable Way to Reach Female Entertainment Workers in Cambodia with Health Messages? A Cross-Sectional Phone Survey. JMIR mHealth and uHealth 2016;4(2):e52
    CrossRef
  21. Betancourt-Cravioto M, Cervantes-Powell P, Tapia-Conyer R, Ledlie S, Gandhi-Banga S. Improved post-marketing safety surveillance of quadrivalent inactivated influenza vaccine in Mexico using a computerized, SMS-based follow-up system. Human Vaccines & Immunotherapeutics 2022;18(1)
    CrossRef
  22. Fukushima A, Iessa N, Balakrishnan MR, Pal SN. Smartphone-based mobile applications for adverse drug reactions reporting: global status and country experience. BMC Medical Informatics and Decision Making 2022;22(1)
    CrossRef
  23. Psihogios A, Brianne Bota A, Mithani SS, Greyson D, Zhu DT, Fung SG, Wilson SE, Fell DB, Top KA, Bettinger JA, Wilson K. A scoping review of active, participant-centred, digital adverse events following immunization (AEFI) surveillance: A Canadian immunization research network study. Vaccine 2022;40(31):4065
    CrossRef
  24. Nyambayo PP, Gold MS, Mehta UC, Clarke S, Manyevere R, Chirinda L, Zifamba EN, Nyamandi T. Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial. Vaccine 2023;41(45):6700
    CrossRef

According to Crossref, the following books are citing this article (DOI 10.2196/jmir.2477):

  1. . Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries. 2018. :163
    CrossRef
  2. Molia S, Bonnet P, Ratnadass A. Family Farming and the Worlds to Come. 2015. Chapter 16:267
    CrossRef
  3. Albrecht U, Pramann O. Re-Engineering Clinical Trials. 2015. :31
    CrossRef
  4. . Pharmacovigilance. 2017. Chapter 15:161
    CrossRef
  5. Bousquet J, Sousa-Pinto B, Puggioni F, Anto A, Balli F, Casale T, Czarlewski W, Bedbrook A, Brussino L, Gaga M, Gemicioglu B, Klimek L, Kvedariene V, Louis R, Sastre J, Scichilone N, Valiulis A, Zervas E, Yorgancioglu A, Zuberbier T, Anto JM, Canonica GW, Fonseca JA. Asthma in the 21st Century. 2023. :231
    CrossRef